• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性乳腺肿瘤的血管与代谢特征之间的关系。

The relationship between vascular and metabolic characteristics of primary breast tumours.

作者信息

Semple Scott I K, Gilbert Fiona J, Redpath Thomas W, Staff Roger T, Ahearn Trevor S, Welch Andrew E, Heys Steven D, Hutcheon Andrew W, Smyth Elizabeth H, Chaturvedi Shailesh

机构信息

Department of Radiology, University of Aberdeen, Lilian Sutton Building, AB252ZD Aberdeen, Scotland, UK.

出版信息

Eur Radiol. 2004 Nov;14(11):2038-45. doi: 10.1007/s00330-004-2454-6. Epub 2004 Aug 14.

DOI:10.1007/s00330-004-2454-6
PMID:15316743
Abstract

The objective of this study was to investigate the relationship between vascular and metabolic characteristics of breast tumours in vivo, using contrast-enhanced dynamic MRI and 2-[(18)F] fluoro-2-deoxy- d-glucose (FDG) PET imaging. Twenty patients with large or locally advanced primary breast cancers were imaged prior to therapy. MRI data were acquired using a dynamic gradient echo sequence and analysed using two pharmacokinetic models. Static PET data were acquired in 2D mode. A significant association ( P<0.05) was observed between the calculated exchange rate constants of both pharmacokinetic models and calculated PET FDG dose uptake ratios (DUR). Statistical analysis showed that the exchange rate constants can explain between 27 and 44% of the variance observed in the PET FDG uptake ratios. A relationship was demonstrated between the vascular and metabolic characteristics of primary breast tumours showing that any assessment of tumour metabolic activity using PET may be controlled at least in part by delivery of uptake agent due to the vascular characteristics of the tumour. MRI and PET provide methods of assessing breast tumour vascularity and metabolism in vivo using the exchange rate constants of dynamic MRI, and DUR of PET, respectively, these measures being related but not equivalent.

摘要

本研究的目的是利用对比增强动态磁共振成像(MRI)和2-[(18)F]氟-2-脱氧-d-葡萄糖(FDG)正电子发射断层扫描(PET)成像,在体内研究乳腺肿瘤的血管和代谢特征之间的关系。20例患有大的或局部晚期原发性乳腺癌的患者在治疗前接受了成像检查。使用动态梯度回波序列采集MRI数据,并使用两种药代动力学模型进行分析。以二维模式采集静态PET数据。在两种药代动力学模型的计算交换率常数与计算得到的PET FDG剂量摄取率(DUR)之间观察到显著相关性(P<0.05)。统计分析表明,交换率常数可以解释PET FDG摄取率中观察到的27%至44%的方差。原发性乳腺肿瘤的血管和代谢特征之间的关系得到了证实,这表明使用PET对肿瘤代谢活性的任何评估可能至少部分受肿瘤血管特征导致的摄取剂递送的控制。MRI和PET分别提供了利用动态MRI的交换率常数和PET的DUR在体内评估乳腺肿瘤血管生成和代谢的方法,这些测量方法相关但不等同。

相似文献

1
The relationship between vascular and metabolic characteristics of primary breast tumours.原发性乳腺肿瘤的血管与代谢特征之间的关系。
Eur Radiol. 2004 Nov;14(11):2038-45. doi: 10.1007/s00330-004-2454-6. Epub 2004 Aug 14.
2
Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration.基线MRI传递特征可预测原发性化疗给药后浸润性导管癌PET代谢的变化。
Ann Oncol. 2006 Sep;17(9):1393-8. doi: 10.1093/annonc/mdl136. Epub 2006 Jun 20.
3
Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma.浸润性导管癌患者中F-18氟脱氧葡萄糖正电子发射断层扫描代谢参数与动态对比增强磁共振成像衍生灌注数据之间的相关性
Ann Surg Oncol. 2015 Nov;22(12):3866-72. doi: 10.1245/s10434-015-4526-z. Epub 2015 Mar 25.
4
Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.使用钆喷酸葡胺/磁共振成像(Gd-DTPA/MRI)和氟代脱氧葡萄糖/正电子发射断层显像((18)F-FDG/PET)进行双药代动力学建模的参考区域方法优化
Magn Reson Med. 2015 Feb;73(2):740-8. doi: 10.1002/mrm.25151. Epub 2014 Mar 6.
5
Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.局部进展期乳腺癌新辅助化疗患者连续动态对比增强 MRI 与动态 18F-FDG PET 测量的相关性。
J Magn Reson Imaging. 2010 Nov;32(5):1124-31. doi: 10.1002/jmri.22362.
6
Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.动态对比增强乳腺磁共振成像的代谢和血管特征以及乳腺癌中(15)O-水正电子发射断层扫描血流情况
Acad Radiol. 2008 Oct;15(10):1246-54. doi: 10.1016/j.acra.2008.03.019.
7
Reliability of F-FDG PET Metabolic Parameters Derived Using Simultaneous PET/MRI and Correlation With Prognostic Factors of Invasive Ductal Carcinoma: A Feasibility Study.使用同步PET/MRI得出的F-FDG PET代谢参数的可靠性及其与浸润性导管癌预后因素的相关性:一项可行性研究。
AJR Am J Roentgenol. 2017 Sep;209(3):662-670. doi: 10.2214/AJR.16.17766. Epub 2017 Jul 5.
8
The relationship between FDG uptake in PET scans and biological behavior in breast cancer.正电子发射断层扫描(PET)中氟代脱氧葡萄糖(FDG)摄取与乳腺癌生物学行为之间的关系。
Breast Cancer. 2007;14(3):260-8. doi: 10.2325/jbcs.14.260.
9
Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.用于测量癌症对治疗反应的18F-FDG摄取定量的动态和静态方法,包括粒细胞集落刺激因子的影响。
J Nucl Med. 2007 Jun;48(6):920-5. doi: 10.2967/jnumed.106.037382. Epub 2007 May 15.
10
Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.18F-FDG PET/CT和DCE-MRI评估乳腺癌患者的肿瘤代谢与灌注率:与肿瘤亚型及组织学预后因素的相关性
Eur J Radiol. 2015 Jul;84(7):1365-70. doi: 10.1016/j.ejrad.2015.03.026. Epub 2015 Mar 30.

引用本文的文献

1
Validation of Clinical Dynamic Contrast-Enhanced Magnetic Resonance Imaging Perfusion Modeling and Neoadjuvant Chemotherapy Response Prediction in Breast Cancer Using FDG and Cu-DOTA-Trastuzumab Positron Emission Tomography Studies.使用氟代脱氧葡萄糖(FDG)和铜-多胺大环配体-曲妥珠单抗正电子发射断层扫描研究对乳腺癌临床动态对比增强磁共振成像灌注模型及新辅助化疗反应预测的验证
JCO Clin Cancer Inform. 2025 Jan;9:e2300248. doi: 10.1200/CCI.23.00248. Epub 2025 Jan 14.
2
F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy.氟代脱氧葡萄糖(F-FDG)专用乳腺正电子发射断层扫描(PET)与乳腺磁共振成像(MRI)互补,用于评估新辅助化疗的早期反应。
Radiol Imaging Cancer. 2024 Mar;6(2):e230082. doi: 10.1148/rycan.230082.
3

本文引用的文献

1
Correlation of MRI/PET rim enhancement in breast cancer: a delivery related phenomenon with therapy implications?
Lancet Oncol. 2003 Dec;4(12):759. doi: 10.1016/s1470-2045(03)01281-6.
2
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.新辅助化疗治疗局部晚期乳腺癌时的血流及代谢变化
J Nucl Med. 2003 Nov;44(11):1806-14.
3
Follow-up of women with breast cancer: comparison between MRI and FDG PET.
Eur Radiol. 2003 Jul;13(7):1635-44. doi: 10.1007/s00330-002-1720-8. Epub 2002 Nov 13.
4
Evaluation of blood supply and metabolism in tumor, axillary lymph node and normal breast tissue with F-18 FDG PET/CT in breast cancer: comparison with pathological prognostic factors.采用 F-18 FDG PET/CT 评估乳腺癌肿瘤、腋窝淋巴结和正常乳腺组织的血供和代谢:与病理预后因素的比较。
BMC Womens Health. 2024 Jan 16;24(1):45. doi: 10.1186/s12905-023-02858-3.
4
Imaging biomarkers for evaluating tumor response: RECIST and beyond.用于评估肿瘤反应的影像生物标志物:RECIST及其他。
Biomark Res. 2021 Jul 2;9(1):52. doi: 10.1186/s40364-021-00306-8.
5
Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.在肝脏肿瘤模型中通过18F-FDG PET与灌注CT联合评估肿瘤内缺氧情况。
PLoS One. 2017 Mar 6;12(3):e0173016. doi: 10.1371/journal.pone.0173016. eCollection 2017.
6
In Vivo Correlation of Glucose Metabolism, Cell Density and Microcirculatory Parameters in Patients with Head and Neck Cancer: Initial Results Using Simultaneous PET/MRI.头颈部癌患者葡萄糖代谢、细胞密度与微循环参数的体内相关性:使用同步PET/MRI的初步结果
PLoS One. 2015 Aug 13;10(8):e0134749. doi: 10.1371/journal.pone.0134749. eCollection 2015.
7
Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.递送率影响荧光葡萄糖类似物在小鼠转移性乳腺癌中的摄取。
PLoS One. 2013 Oct 18;8(10):e76524. doi: 10.1371/journal.pone.0076524. eCollection 2013.
8
Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging.三阴性和非三阴性浸润性乳腺癌:MR 与氟 18 氟代脱氧葡萄糖 PET 成像的相关性。
Radiology. 2013 Nov;269(2):354-61. doi: 10.1148/radiol.13130058. Epub 2013 Jul 22.
9
¹⁸F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer.¹⁸F-FDG PET/CT 成像与动态对比增强 CT 用于炎性乳腺癌的分期和预后评估。
Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1206-13. doi: 10.1007/s00259-013-2405-z. Epub 2013 May 3.
10
Pretreatment PET in breast cancer: is there a role?乳腺癌的预处理正电子发射断层扫描:有作用吗?
Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1827-9. doi: 10.1007/s00259-012-2216-7.
Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model.肥胖状态下骨骼肌中的葡萄糖转运与磷酸化:来自肌肉特异性正电子发射断层扫描模型的见解
J Clin Endocrinol Metab. 2003 Mar;88(3):1271-9. doi: 10.1210/jc.2002-021304.
5
FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers.
Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):274-80. doi: 10.1007/s00259-002-1022-z. Epub 2002 Nov 20.
6
Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy.乳腺磁共振成像用于监测原发性乳腺癌对新辅助化疗的反应。
Eur Radiol. 2002 Jul;12(7):1711-9. doi: 10.1007/s00330-001-1233-x. Epub 2002 Feb 14.
7
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.局部晚期乳腺癌的血流与代谢:与治疗反应的关系。
J Nucl Med. 2002 Apr;43(4):500-9.
8
Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging.使用动态对比增强磁共振成像评估肿瘤血管功能的变化。
NMR Biomed. 2002 Apr;15(2):154-63. doi: 10.1002/nbm.756.
9
Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience.
Eur Radiol. 2001;11(10):2058-70. doi: 10.1007/s003300100944.
10
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.使用[(18)F] - 氟脱氧 - D - 葡萄糖的正电子发射断层扫描来预测乳腺癌对原发性化疗的病理反应。
J Clin Oncol. 2000 Apr;18(8):1676-88. doi: 10.1200/JCO.2000.18.8.1676.